> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Withdraws Potassium Aminobenzoate Products
- URL: https://www.fdaweb.com/fda-withdraws-potassium-aminobenzoate-products/
- Published: 2022-03-08T12:00:00.000Z
- Updated: 2026-09-14T17:35:42.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5151310

*Federal Register* notice: FDA has announced that all outstanding hearing requests regarding potassium aminobenzoate tablets, capsules, powder, and envules under Docket No. FDA-1977-N-0015 (formerly 77N-0187) as part of the Drug Efficacy Study Implementation have been withdrawn. Therefore, FDA has determined that the products have not been shown to be effective for use under the conditions of use prescribed, recommended, or suggested in the labeling, and withdraws approval of the application under the Federal Food, Drug, and Cosmetic Act. To view the notice, click [here](https://public-inspection.federalregister.gov/2022-04971.pdf?ref=fdaweb.com).